REGULATORY

• Trade Groups Urges New Reimbursement Fee Evaluation for SaMD
  August 26, 2021

• Takeda’s Pevonedistat Gets 1st Sakigake Tag under PMD Law
  August 26, 2021

• COVID-19 Antibody Cocktail to Be Made Available for Outpatients Too: Minister
  August 25, 2021

• Orphan Status Granted to Fenfluramine, Asciminib, Vosoritide
  August 25, 2021

• Pharma Leaders Support Draft Industry Vision, but Stress Need for Price Maintenance of Patented Meds: Confab
  August 25, 2021

• PAFSC to Review Astellas’ Padcev, Pfizer’s JAK Inhibitor, AZ’s Lupus Drug and More
  August 24, 2021

• Takeda’s 1st Cell Therapy Up for PAFSC Review on Sept. 6
  August 24, 2021

• MHLW to Seek Budget to Boost GMP Inspections to Secure Trust in Generics: FY2022 Request
  August 23, 2021

• New Pharma Vision to Set Out Clear Goal, KPIs after Lawmaker Calls
  August 23, 2021

• Sharp Drop in Suspected Violations Seen in FY2020 Drug Promotion, but Comparison Difficult due to COVID-19: MHLW
  August 23, 2021

• MHLW’s FY2022 Budget Request to Focus on COVID-19 R&D, Quality Generic System
  August 20, 2021

• Japan Panel OKs COVID-19 Vaccine Health Damage Claims for First Time
  August 20, 2021

• Japan Secures Enough Doses for Booster Shots Next Year: Minister
  August 18, 2021

• Public-Private Dialogue for New Pharma Vision Set for Aug. 24
  August 18, 2021

• Otsuka’s Eczema Med, Alexion’s Blood Thinner Antidote Up for PAFSC Review on Aug. 30
  August 17, 2021

• 14 Firms Flock to Get Approval for E Keppra Generics towards December Listing
  August 17, 2021

• MHLW OKs Ronapreve Use in Short-Term Hospitalization and at Accommodation Facilities
  August 17, 2021

• Kono Says Vaccine Rollout Sped Up as Japan Hits 100 Million Dose Mark
  August 11, 2021

• Japan to Run Follow-Up Survey for AstraZeneca Vaccine at 6 Hospitals
  August 11, 2021

• Prefectural Governors Urge Booster Shot with AstraZeneca Jabs
  August 11, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 140
• 141
• 142
• 143
• 144
• 145
• 146
• 147
• 148
• …
• Next ›
• 最終 »